Are Psychedelics Ethically Exceptional After All? Some Further Reflections
Katherine Cheung, Brian D. Earp, Kyle Patch, David B. Yaden
The American Journal of Bioethics 2026 DOI: 10.1080/15265161.2026.2637063 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Key points | Argues that psychedelics do not warrant exceptional ethical treatment relative to other medical and research domains. |
Abstract
We are grateful to those who commented on our Target Article on ethical exceptionalism around psychedelics (see Box 1 for a summary of our main points) and to Cohen and Marks (2025) for their compl...
Citations in the library
Cites 17
- Distinctive But Not Exceptional: The Risks of Psychedelic Ethical Exceptionalism. The American Journal of Bioethics 2025
- The Hopkins-Oxford Psychedelics Ethics (HOPE) Working Group Consensus Statement The American Journal of Bioethics May 2, 2024
- Psychedelics, Meaningfulness, and the "Proper Scope" of Medicine: Continuing the Conversation. Cambridge Quarterly of Healthcare Ethics June 27, 2023
- Psychedelic Medicine Exceptionalism. The American Journal of Bioethics 2025
- Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals. Scientific Reports November 14, 2024
and 12 more in the library